<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Med (Lausanne)</journal-id><journal-id journal-id-type="iso-abbrev">Front Med (Lausanne)</journal-id><journal-id journal-id-type="publisher-id">Front. Med.</journal-id><journal-title-group><journal-title>Frontiers in Medicine</journal-title></journal-title-group><issn pub-type="epub">2296-858X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC12098060</article-id><article-id pub-id-type="doi">10.3389/fmed.2025.1533344</article-id><article-categories><subj-group subj-group-type="heading"><subject>Medicine</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>The microbiome in endometrial cancer: vaginal milieu matters</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Govorov</surname><given-names>Igor</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref><uri xlink:href="http://loop.frontiersin.org/people/648769/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/software/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Komlichenko</surname><given-names>Eduard</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Ulrikh</surname><given-names>Elena</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Dikareva</surname><given-names>Elena</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Pervunina</surname><given-names>Tatiana</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Vazhenina</surname><given-names>Oksana</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Dzharbaeva</surname><given-names>Amina</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Kalinina</surname><given-names>Olga</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Zaikova</surname><given-names>Ekaterina</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Razumova</surname><given-names>Zoia</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Mints</surname><given-names>Miriam</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Sitkin</surname><given-names>Stanislav</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><xref rid="aff7" ref-type="aff">
<sup>7</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Almazov National Medical Research Centre</institution>, <addr-line>Saint-Petersburg</addr-line>, <country>Russia</country></aff><aff id="aff2"><sup>2</sup><institution>Division of Obstetrics and Gynecology, Department of Women's and Children's Health, Karolinska Institutet</institution>, <addr-line>Stockholm</addr-line>, <country>Sweden</country></aff><aff id="aff3"><sup>3</sup><institution>St Petersburg University</institution>, <addr-line>Saint-Petersburg</addr-line>, <country>Russia</country></aff><aff id="aff4"><sup>4</sup><institution>North-Western State Medical University named after I.I. Mechnikov</institution>, <addr-line>Saint-Petersburg</addr-line>, <country>Russia</country></aff><aff id="aff5"><sup>5</sup><institution>National Medical Research Centre of Oncology named after N.N. Petrov</institution>, <addr-line>Saint-Petersburg</addr-line>, <country>Russia</country></aff><aff id="aff6"><sup>6</sup><institution>School of Medical Science, Faculty of Medicine and Health, &#x000d6;rebro University</institution>, <addr-line>&#x000d6;rebro</addr-line>, <country>Sweden</country></aff><aff id="aff7"><sup>7</sup><institution>Institute of Experimental Medicine</institution>, <addr-line>Saint-Petersburg</addr-line>, <country>Russia</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Kunqi Chen, Fujian Medical University, China</p></fn><fn fn-type="edited-by"><p>Reviewed by: Elizabeth Garc&#x000ed;a-G&#x000f3;mez, Secretar&#x000ed;a de Ciencia Tecnolog&#x000ed;a e Innovaci&#x000f3;n, Mexico</p><p>Brunella Perfetto, University of Campania Luigi Vanvitelli, Italy</p></fn><corresp id="c001">*Correspondence: Igor Govorov <email>govorov_ie@almazovcentre.ru</email></corresp></author-notes><pub-date pub-type="epub"><day>09</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>12</volume><elocation-id>1533344</elocation-id><history><date date-type="received"><day>02</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>11</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 Govorov, Komlichenko, Ulrikh, Dikareva, Pervunina, Vazhenina, Dzharbaeva, Kalinina, Zaikova, Razumova, Mints and Sitkin.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Govorov, Komlichenko, Ulrikh, Dikareva, Pervunina, Vazhenina, Dzharbaeva, Kalinina, Zaikova, Razumova, Mints and Sitkin</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Endometrial cancer remains one of the most common malignancies in women, and its incidence is particularly increasing in developed countries. Despite the well-known promotive role of excessive exposure to estrogen, many other details of the pathogenesis of endometrial cancer remain unknown. Recent studies have elucidated the emerging role of the resident microbiota in the progression of various diseases, including cancer. Next-generation sequencing demonstrated that the uterine cavity, previously considered sterile, contains a composition-rich microbiota. In this work, we determined the differences in the composition of the intrauterine microbiota between patients with endometrial cancer and its precursor&#x02014;endometrial hyperplasia.</p></abstract><kwd-group><kwd>endometrial cancer</kwd><kwd>microbiota</kwd><kwd>endometrial microbiota</kwd><kwd>endometrial hyperplasia</kwd><kwd>carcinogenesis</kwd><kwd>vaginal microbiota</kwd></kwd-group><funding-group><award-group><funding-source id="cn001"><institution-wrap><institution>Ministry of Science and Higher Education of the Russian Federation</institution><institution-id institution-id-type="doi">10.13039/501100012190</institution-id></institution-wrap></funding-source></award-group><funding-statement>The author(s) declare that financial support was received for the research and/or publication of this article. This work was financially supported by the Ministry of Science and Higher Education of the Russian Federation (Agreement No. 075-15-2022-301). Endometrial brushes were provided by Karolinska Institutet.</funding-statement></funding-group><counts><fig-count count="9"/><table-count count="1"/><equation-count count="0"/><ref-count count="58"/><page-count count="10"/><word-count count="5979"/></counts><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Obstetrics and Gynecology</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Endometrial cancer (EC) is the most common gynecological malignancy in developed countries, second only to cervical cancer in the developing part of the world. Unlike many other cancers, the incidence of EC and associated mortality have been increasing in recent decades (<xref rid="B1" ref-type="bibr">1</xref>). Most EC cases (around 80%) are histologically endometrioid, present early, and have a more favorable prognosis. These cases are known under the group name Type 1 EC tumors, first described by Bokhman (<xref rid="B2" ref-type="bibr">2</xref>). The rest - serous, clear cell, mucinous, and several others - were grouped under the name Type 2 EC tumors. Type 1 tumors usually contain sex steroid receptors and arise from hyperplastic preconditions, such as endometrial hyperplasia (EH). Their development is traditionally related to unopposed exposure to estrogens. The latter may be the consequence of the action of risk factors, including, but are not limited to, obesity, nulliparity, estrogen therapy, etc.</p><p>However, in light of new publications and the discoveries of the new genomic atlas, endometrial cancers seem to be more heterogeneous (<xref rid="B3" ref-type="bibr">3</xref>). The four distinct subtypes were described: DNA polymerase epsilon ultra-mutated, microsatellite instability hypermutated, copy-number low, and copy-number high. The recent studies suggest that microbiota can also play role in EC tumorogenesis (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>). While the vaginal microbiota is well-known to be active and dominated by the <italic>Lactobacilli</italic> genus, the uterine cavity was previously considered sterile (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>). The advent of next-generation sequencing (NGS) technologies revealed that the uterine microbiota is more scarce than the vaginal (10<sup>3</sup>-10<sup>5</sup> times lower), but simultaneously more diverse (<xref rid="B8" ref-type="bibr">8</xref>). The origin of the intrauterine microbial community and its role in health and disease is an emerging area of research. For instance, recent studies suggested that the endometrial microbiota can modulate uterine receptivity and therefore influence fertility (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B10" ref-type="bibr">10</xref>). Furthermore, the composition of the uterine microbiota has been associated with various gynecological conditions, including endometriosis, dysfunctional menstrual bleeding, and cancer (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B11" ref-type="bibr">11</xref>). The current study was conducted to provide a comparative analysis of the reproductive tract microbiota between patients with EH and EC.</p></sec><sec sec-type="materials and methods" id="s2"><title>Materials and methods</title><sec><title>Study group</title><p>We included patients who were referred to the Almazov National Medical Research Center from March 2020 to November 2021, due to thickened endometrium on ultrasound and/or abnormal uterine bleeding. The samples were collected and stored prospectively (see below) but were not included in the study before the final histopathological diagnosis. Then the patients were grouped in either of two groups&#x02014;EH or EC.</p><p>Patients were advised against vaginal douching or using vaginal suppositories. None of the patients had previously received menopausal hormone therapy. The exclusion criteria also included tamoxifen use, inflammatory bowel disease, antibiotic use within previous 3 months.</p></sec><sec><title>Sample processing</title><p>Samples were collected according to the following method. All procedures were performed in a sterile environment within the operating room by the surgeon. High vaginal swabs (from the posterior fornix) were collected before applying the disinfectants shortly after administering the anesthesia. Routine pre-surgical douching with betadine was then performed. Endometrial samples were collected using disposable tools, Endometrial Tao Brush&#x02122; by Coop Medical. It has a protective shield, which helps avoid cross-contamination with the lower parts (vagina, cervical canal) and was previously described as a reliable tool for collecting intrauterine samples (<xref rid="B12" ref-type="bibr">12</xref>). The samples were then quickly delivered for storage in liquid nitrogen.</p></sec><sec><title>DNA extraction and 16S rDNA sequencing</title><p>Total DNA was extracted using the FlexiGene DNA Kit (Qiagen, Hilden, Germany) following the manufacturer's instructions. DNA quality was assessed using a NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). The DNA was stored at -20&#x000b0;C until use.</p><p>Libraries were generated with NEXTflex 16S V4 Amplicon-Seq Kit 2.0 (PerkinElmer, Inc., Waltham, MA, United States), according to the manufacturer's instructions. Sequencing was performed on the MiSeq platform with MiSeq Reagent Kit v2 (250 bp &#x000d7; 2) (Illumina Inc., San Diego, CA, United States).</p></sec><sec><title>Bioinformatic analysis</title><p>Files with forward and reverse reads were subjected to primary quality control using the FastQC v0.11.9 (<xref rid="B13" ref-type="bibr">13</xref>) and MultiQC v1.14 (<xref rid="B14" ref-type="bibr">14</xref>) programs. Filtering of data with low quality value, removal of adapter sequences and primers was performed using the trimmomatic program v0.39 (<xref rid="B15" ref-type="bibr">15</xref>) (adapters: 2:30:10 SLIDINGWINDOW: 4:15 HEADCROP (primer length) MINLEN 150). Then a second quality analysis was carried out. The reads were analyzed using the DADA2 package for R v1.26.0 (<xref rid="B16" ref-type="bibr">16</xref>). Since the merging of forward and reverse readings led to a large reduction in the number of sequences, only direct readings were used for analysis. Quality control was repeated with the DADA2 package, chimeric reads and low-quality readings were removed. The obtained amplicon sequence variants (ASVs) were clustered using the mmseq2 v 13.45111 (<xref rid="B17" ref-type="bibr">17</xref>) with the identity parameter - 99% and 97%, and coverage of 80% to obtain operational taxonomic units (OTUs). The taxonomic analysis of the obtained sequences was carried out in the DADA 2 package based on the SILVA v138.1 database.</p><p>Alpha and beta diversity was compared using the phyloseq v1.42.0 package (<xref rid="B18" ref-type="bibr">18</xref>). Alpha diversity was evaluated according to the Chao1, Shannon and Simpson criteria. To visually assess beta diversity, a principal coordinate analysis (PCoA) was performed using the Weighted UniFrac algorithm. The LEfSe package microbiomeMarker v1.4.0 (<xref rid="B19" ref-type="bibr">19</xref>) was used to detect the bacterial markers that contribute the most to the difference between the two groups.</p></sec><sec><title>Statistics</title><p>Statistical analysis was carried out using R packages. Permutational multivariate analysis of variance (PERMANOVA) was performed using the vegan v2 package.6.4 (<xref rid="B20" ref-type="bibr">20</xref>), the adonis2() function. Mann-Whitney-Wilcoxon test were used to compare the distribution of the continuous variables between the groups. Chi-square was used to test relationships between categorical variables (together with Yates' correction for continuity when needed).</p></sec><sec sec-type="data-availability"><title>Data availability</title><p>The 16S rDNA data is available upon request and will be shortly deposited at the NCBI sequence read archive.</p></sec><sec><title>Ethics declaration</title><p>The current study was approved by the Institutional Ethical Board <sans-serif>No</sans-serif> 0306-20 on 15.06.2020. All patients signed informed consent before entering the study.</p></sec></sec><sec sec-type="results" id="s3"><title>Results</title><sec><title>Background characteristics</title><p>Both EC and EH groups included 27 patients. EC patients were predominantly older and postmenopausal. There were no differences in severity, parity, or BMI, although the patients in both groups tended to be overweight (<xref rid="T1" ref-type="table">Table 1</xref>). Within the EC group patients mostly had localized type I cancer, except one patient, who had serous carcinoma.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Background patients' characteristics.</p></caption><table frame="box" rules="all"><thead><tr style="background-color:#919498;color:#ffffff"><th valign="top" align="left" colspan="2" rowspan="1"/><th valign="top" align="center" rowspan="1" colspan="1">
<bold>EC group (<italic>n</italic> = 27)</bold>
</th><th valign="top" align="center" rowspan="1" colspan="1">
<bold>EH group (<italic>n</italic> = 27)</bold>
</th><th valign="top" align="center" rowspan="1" colspan="1">
<bold><italic>P</italic>-value</bold>
</th></tr></thead><tbody><tr><td valign="top" align="left" colspan="2" rowspan="1">Age, years Median &#x000b1; IQR</td><td valign="top" align="center" rowspan="1" colspan="1">65.00 [59.00, 69.00]</td><td valign="top" align="center" rowspan="1" colspan="1">55.00 [45.50, 60.00]</td><td valign="top" align="center" rowspan="1" colspan="1">0.002*</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">BMI Median &#x000b1; IQR</td><td valign="top" align="center" rowspan="1" colspan="1">32.80 [27.45, 39.50]</td><td valign="top" align="center" rowspan="1" colspan="1">29.00 [25.25, 32.70]</td><td valign="top" align="center" rowspan="1" colspan="1">0.063</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Menopause, <italic>n</italic> (%)</td><td valign="top" align="center" rowspan="1" colspan="1">24 (88.9)</td><td valign="top" align="center" rowspan="1" colspan="1">16 (59.3)</td><td valign="top" align="center" rowspan="1" colspan="1">0.030*</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Number of pregnancies, Mean (SD)</td><td valign="top" align="center" rowspan="1" colspan="1">3.00 (2.42)</td><td valign="top" align="center" rowspan="1" colspan="1">3.00 (2.48)</td><td valign="top" align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td valign="top" align="left" colspan="2" rowspan="1">Number of childbirth, Mean (SD)</td><td valign="top" align="center" rowspan="1" colspan="1">1.48 (1.37)</td><td valign="top" align="center" rowspan="1" colspan="1">1.33 (1.00)</td><td valign="top" align="center" rowspan="1" colspan="1">0.652</td></tr><tr><td valign="top" align="left" rowspan="72" colspan="1">Stage, <italic>n</italic> (%)</td><td valign="top" align="left" rowspan="1" colspan="1">IA</td><td valign="top" align="center" rowspan="1" colspan="1">14 (51.9)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">IB</td><td valign="top" align="center" rowspan="1" colspan="1">6 (22.2)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">II</td><td valign="top" align="center" rowspan="1" colspan="1">3 (11.1)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">IIIA</td><td valign="top" align="center" rowspan="1" colspan="1">1 (3.7)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">IIIC1</td><td valign="top" align="center" rowspan="1" colspan="1">1 (3.7)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">IIIC2</td><td valign="top" align="center" rowspan="1" colspan="1">1 (3.7)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">IVB</td><td valign="top" align="center" rowspan="1" colspan="1">1 (3.7)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="3" colspan="1">Grade, n (%)</td><td valign="top" align="left" rowspan="1" colspan="1">G1</td><td valign="top" align="center" rowspan="1" colspan="1">11 (40.7)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">G2</td><td valign="top" align="center" rowspan="1" colspan="1">6 (22.2)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">G3</td><td valign="top" align="center" rowspan="1" colspan="1">10 (37.0)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td></tr></tbody></table><table-wrap-foot><p>BMI, body mass index; EC, endometrial cancer; EH, endometrial hyperplasia; IQR, interquartile range; *statistically significant.</p></table-wrap-foot></table-wrap></sec><sec><title>Uterine microbiota composition</title><p>In total 49 uterine samples were obtained (5 were discarded due to unsatisfactory quality). After potentially human sequences were subtracted, the number of reads equaled zero in two samples. Therefore, 47 samples were included in the final analysis, with 24 and 23 in the EC and EH groups, respectively. <xref rid="F1" ref-type="fig">Figure 1</xref> shows the alpha-diversity of the uterine samples, according to Chao1, Shannon and Simpson respectively.</p><fig position="float" id="F1"><label>Figure 1</label><caption><p>Alpha-diversity of the uterine samples according to different metrics.</p></caption><graphic xlink:href="fmed-12-1533344-g0001" position="float"/></fig><p>The intergroup diversity between two groups was analyzed using PCoA and weighted Unifrac algorithms. The results are presented in <xref rid="F2" ref-type="fig">Figure 2</xref>. Additionally, PERMANOVA was used to analyze the data. As a result, a <italic>p</italic>-value of 0.006 was obtained, indicating a statistical difference between the two groups.</p><fig position="float" id="F2"><label>Figure 2</label><caption><p>Beta-diversity of the uterine samples in 1:2 and 2:3 projections.</p></caption><graphic xlink:href="fmed-12-1533344-g0002" position="float"/></fig><p>When analyzing the taxonomic diversity of the uterine microbiome, 15 different families of bacteria were identified (<xref rid="F3" ref-type="fig">Figure 3</xref>). The most prevalent families included <italic>Porphyromonadaceae, Prevotellaceae, Actinomycetaceae</italic>, and <italic>Enterococcaceae</italic>.</p><fig position="float" id="F3"><label>Figure 3</label><caption><p>The taxonomic composition of uterine microbiota samples at the level of bacterial families.</p></caption><graphic xlink:href="fmed-12-1533344-g0003" position="float"/></fig><p>The LEfSe method revealed that four intrauterine bacterial agents were enriched in EH group and by that contributed the most to the differences between the groups (<xref rid="F4" ref-type="fig">Figure 4</xref>). These were <italic>Lactobacillus iners</italic>, and unknown species of the genera <italic>Lactobacillus, Enterococcus</italic> and <italic>Bifidobacterium</italic> genera.</p><fig position="float" id="F4"><label>Figure 4</label><caption><p>Bacterial agents, that were enriched in EH group, according to LEfSe analysis.</p></caption><graphic xlink:href="fmed-12-1533344-g0004" position="float"/></fig></sec><sec><title>Vaginal microbiota composition</title><p>In total 44 vaginal samples were obtained (excluding those with preanalytical flaws), of which 23 belonged to the EC group and 21 belonged to the EH group. <xref rid="F5" ref-type="fig">Figure 5</xref> shows the alpha diversity of the vaginal samples, according to Chao1, Shannon, and Simpson, respectively.</p><fig position="float" id="F5"><label>Figure 5</label><caption><p>Alpha-diversity of the vaginal samples according to different metrics.</p></caption><graphic xlink:href="fmed-12-1533344-g0005" position="float"/></fig><p>The intergroup diversity for the vaginal samples is presented in <xref rid="F6" ref-type="fig">Figure 6</xref>. The PERMANOVA analysis revealed a <italic>p</italic>-value of 0.01. This indicates that the two sets of samples statistically differ from each other in terms of beta diversity.</p><fig position="float" id="F6"><label>Figure 6</label><caption><p>Beta-diversity of the vaginal samples in 1:2 and 2:3 projections.</p></caption><graphic xlink:href="fmed-12-1533344-g0006" position="float"/></fig><p>Taxonomic analysis revealed the presence of 26 different classes of bacteria. <xref rid="F7" ref-type="fig">Figure 7</xref> illustrates the top-15 families. The most prevalent families were <italic>Prevotellaceae (Bacteroidota), Bifidobacteriaceae (Actinomycetota), Porphyromonadaceae (Bacteroidota)</italic>, and <italic>Corynebacteriaceae (Actinomycetota)</italic>.</p><fig position="float" id="F7"><label>Figure 7</label><caption><p>The taxonomic composition of vaginal microbiota samples at the level of bacterial families.</p></caption><graphic xlink:href="fmed-12-1533344-g0007" position="float"/></fig><p>The LefSe method identified nine biomarkers, two of which were enriched in EH group&#x02014;<italic>Lactobacillus (Bacillota)</italic> and <italic>Actinomycetaceae (Actinomycetota)</italic> and seven - in EC group (<xref rid="F8" ref-type="fig">Figure 8</xref>). The latter included <italic>Porphyromonas spp, Prevotella corporis</italic> (both <italic>Bacteroidota</italic>); <italic>Streptococcus spp, Moryella spp, Peptococcus niger, Criibacterium spp</italic> and <italic>Clostridiales</italic> bacterium S5 A14a (all belong to <italic>Bacillota</italic>).</p><fig position="float" id="F8"><label>Figure 8</label><caption><p>Comparison of bacterial agents, that were enriched in vagina in both groups.</p></caption><graphic xlink:href="fmed-12-1533344-g0008" position="float"/></fig><p>After excluding samples with low number of reads, 32 samples were analyzed pairwise (14 in Cancer group, 18 in Hyperplasia group). Paired samples with hyperplasia were more similar to each other than paired samples in the cancer group (<xref rid="F9" ref-type="fig">Figure 9</xref>). However, <italic>p</italic>-value was 0.1315, therefore not allowing us to draw a definitive conclusion.</p><fig position="float" id="F9"><label>Figure 9</label><caption><p>Pairwise samples comparison using Bray-Curtis distance metric.</p></caption><graphic xlink:href="fmed-12-1533344-g0009" position="float"/></fig></sec></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>In the current study we investigated differences in microbiota composition both in the vagina and the uterus between EH and EC patients. The results indicate the presence of a scarce but diverse microbial community within the uterus, as shown by several intragroup diversity parameters, the Chao1, Shannon, and Simpson index. Furthermore, both the vaginal and endometrial microbial composition <italic>per se</italic> differs between the groups with possible explanations and implications to be described below.</p><p>The existence of bacteria in the uterus has long been a controversial topic, with early research relying on culture-based methods suggesting the uterus was sterile. This may be due to the imperfections of the method, as well as the fact that some bacteria are known to grow poorly on artificial media. However, recent culture-independent studies using next-generation sequencing have revealed the presence of diverse microbial communities in the uterus, referred to as the uterine microbiota (<xref rid="B21" ref-type="bibr">21</xref>). In healthy women, the uterine microbiota appears to be low in biomass, but highly diverse, containing bacteria belonging mainly to the <italic>Lactobacillus (Bacillota), Prevotella (Bacteroidota), Gardnerella</italic>, and <italic>Atopobium</italic> (both belong to <italic>Actinomycetota</italic>) (<xref rid="B22" ref-type="bibr">22</xref>). The specific composition of the microbiota varies according to factors such as the menstrual cycle, parity and menopausal status (<xref rid="B23" ref-type="bibr">23</xref>). In postmenopausal women, the uterine mileue was enriched in Flavobacterium (Bacteroidota) compared to the cervicovaginal and anorectal microbiota (<xref rid="B24" ref-type="bibr">24</xref>). In contrast, in nulliparous women with abnormal uterine bleeding <italic>Prevotella, Fusobacterium</italic> and <italic>Jonquetella</italic> were the most abundant taxa (<xref rid="B25" ref-type="bibr">25</xref>). Infertility, endometriosis, and oncogynecological diseases are among the most studied areas in the context of microbial influence (<xref rid="B26" ref-type="bibr">26</xref>&#x02013;<xref rid="B28" ref-type="bibr">28</xref>).</p><p>The uterus is an immunologically priveleged organ: it can accommodate tissue invasion by immunologically semiforeign placental cells, yet maintain mucosal immune defenses against ascending foreign organisms, and provide a system to efficiently clear the endometrial detritus that results from menstruation. The relations between the human body and the resident microbiota are an emerging scientific topic, which has not yet been described. Sometimes, the microbe-host interactions are simplified by saying that these two entities apply oppositely directed forces: The microbes strive to thwart host defense and multiply infinitely, while the host puts all efforts into eradicating the microorganisms. Although this might be acceptable or at least pragmatic for using this model for acute infections, the pattern of how the host interacts with the resident microbiota is not linear and is best described by the Nash dynamic equilibrium (<xref rid="B29" ref-type="bibr">29</xref>). In such a model, a host sequesters a microbe community within defined locus (should that be the enteric lumen or endometrial cavity) and does not favor their spread beyond these borders.</p><p>In our study members of both <italic>Porphyromonadaceae</italic> and <italic>Prevotellaceae</italic> families were among the most prevalent bacteria in the vagina and the uterus. This is in accordance with the previous studies. For example, the study by Caselli et al. showed that both <italic>Atopobium vaginae</italic> and <italic>Porphyromonas somerae</italic> induced the expression of pro-inflammatory cytokines in endometrial cells, which could have implications for the development of endometrial cancer (<xref rid="B30" ref-type="bibr">30</xref>). Based on sequencing of the 16S rDNA V3-V5 region from the reproductive tract, Walther-Ant&#x000f3;nio et al. suggest that the detection of <italic>Atopobium vaginae</italic> and <italic>Porphyromonas sp</italic>. in the gynecologic tract combined with a vaginal pH greater than 5, had a sensitivity of 100% and specificity of 60% to detect EC (<xref rid="B31" ref-type="bibr">31</xref>). In a recent study by the same group (<xref rid="B32" ref-type="bibr">32</xref>) <italic>Porphyromonas</italic> was described as a robust biomarker of EC. <italic>Porphyromonas uenonis</italic> was more common in vaginal specimens from patients with both high-grade and low-grade endometrial cancers than from those with benign conditions (<xref rid="B33" ref-type="bibr">33</xref>). Wang et al. studied the microbiota in EC and adjacent tissue samples and found that several genera were enriched in malignant loci&#x02014;<italic>Porphyromonas, Prevotella, Atopobium, Anaerococcus, Dialister</italic>, and <italic>Peptoniphilus</italic> (<xref rid="B5" ref-type="bibr">5</xref>). Li et al. provided evidence that tumor burden is associated with the presence of a specific endometrial microbiota, which is distinguished by the enrichment of <italic>Pelomonas</italic> and <italic>Prevotella</italic> in patients with EC (<xref rid="B34" ref-type="bibr">34</xref>). Transcriptomic data identified the upregulation of eight genes involved in pathways associated with fibrin degradation, including those with proteolysis and transcription factor activities. Hence, the authors concluded that <italic>Prevotella</italic> may promote fibrin degradation by inducing the expression of specific genes. It should be also noted, that <italic>Porphyromonas</italic> was previously described as carcinogenic within the digestive tract, due to its ability of inducing immune responses in the host (<xref rid="B35" ref-type="bibr">35</xref>).</p><p>In the current study, potential biomarkers for endometrial cancer have only been identified in the vaginal microbiota. Typically absent from the normal vaginal microbiota, including <italic>Porphyromonas, Prevotella corporis, Streptococcus, Moryella, Peptococcus niger, Criibacterium</italic> and <italic>Clostridiales bacterium S5 A14a</italic>. Notably, vaginal <italic>Porphyromonas</italic> and <italic>Prevotella</italic>, along with <italic>Bacteroides, Mycoplasma, Bacillus, Dialister</italic>, and <italic>Anaerococcus</italic>, have recently been identified as indicators of cervical cancer (<xref rid="B36" ref-type="bibr">36</xref>). <italic>Prevotella corporis</italic>, an established human pathogen, along with <italic>Prevotella bivia</italic> and <italic>Prevotella disiens</italic>, originates from the urogenital tract (<xref rid="B37" ref-type="bibr">37</xref>), but can also be an odontogenic pathogen (<xref rid="B38" ref-type="bibr">38</xref>). <italic>Prevotella corporis</italic>, an anaerobic bacterium rarely mentioned in the literature, was previously found to be associated with bacterial vaginosis, including in pregnant women (<xref rid="B39" ref-type="bibr">39</xref>), and has never been reported to be associated with EC until the current study. However, other <italic>Prevotella</italic> species and the <italic>Prevotella</italic> genus in general have previously been found to be associated with various gynecological cancers. <italic>Prevotella bivia</italic> was one of two species, along with <italic>Fusobacterium ulcerans</italic>, significantly more abundant in high grade compared to low grade endometrial carcinoma (<xref rid="B33" ref-type="bibr">33</xref>), and even earlier was found associated with cervical cancer (<xref rid="B40" ref-type="bibr">40</xref>). As previously shown, the abundance of vaginal <italic>Prevotella</italic> and <italic>Streptococcus</italic> was increased in the group of gynecological cancers (<xref rid="B41" ref-type="bibr">41</xref>). Although <italic>Prevotella</italic> spp. generally cause minimal proinflammatory epithelial activation, they may induce changes to the cellular physiology and integrity of the endometrial epithelium in a species-specific fashion. <italic>Prevotella</italic> spp. can form biofilms, alter the epithelial barrier, and impact the colonization of secondary colonizers (<xref rid="B42" ref-type="bibr">42</xref>).</p><p><italic>Moryella</italic>, currently represented by a single species <italic>Moryella indoligenes</italic>, is a minor component of the vaginal microbiome (<xref rid="B43" ref-type="bibr">43</xref>), closely correlated with bacterial vaginosis (<xref rid="B44" ref-type="bibr">44</xref>). This bacterium, along with <italic>Prevotella</italic>, was previously described as being abundant in the vaginal samples from the females with EC (<xref rid="B45" ref-type="bibr">45</xref>). The association with gastrointestinal cancer was also reported (<xref rid="B46" ref-type="bibr">46</xref>).</p><p><italic>Peptococcus niger</italic>, is an established human pathogen, previously found in a healthy vaginal ecosystem (<xref rid="B47" ref-type="bibr">47</xref>). This species has not previously been reported to be associated with gynecological cancers, however, it was previously identified in oral swabs in patients with potentially malignant disorders (<xref rid="B48" ref-type="bibr">48</xref>).</p><p><italic>Criibacterium</italic> a genus with a single specie <italic>Criibacterium bergeronii</italic> isolated from human clinical samples, was shown to be enriched in the EC tissues, as mentioned in the work by Wang et al. (<xref rid="B5" ref-type="bibr">5</xref>). <italic>Criibacterium bergeronii</italic>, besides <italic>Streptococcus pyogenes</italic>, was the only other bacterial species enriched in idiopathic cutaneous ulcers in children after community-based mass treatment with azithromycin (<xref rid="B49" ref-type="bibr">49</xref>).</p><p><italic>Clostridiales bacterium S5 A14a</italic> and <italic>Anaerovoracaceae</italic> family to which this bacterium probably belongs were found to be abundant in vaginal swabs in patients who had previous malignancies (<xref rid="B50" ref-type="bibr">50</xref>). In addition, <italic>Clostridiales bacterium S5-A14a</italic> was one of the taxa differentiating healthy control and post-treatment cervical swab samples in premenopausal women with squamous cell carcinoma of the cervix (<xref rid="B51" ref-type="bibr">51</xref>).</p><p>Intriguingly, the genes of <italic>Porphyromonas, Prevotella, Streptococcus</italic>, and <italic>Peptococcus niger</italic> can be classified as part of the estrobolome. The first three taxa can encode &#x003b2;-galactosidases, and <italic>Peptococcus niger</italic> can encode sulfatases and convert estrone sulfate to estrone, influencing active estrogen levels - the major risk-factor for EC (<xref rid="B52" ref-type="bibr">52</xref>, <xref rid="B53" ref-type="bibr">53</xref>). In a recent study, for example, changes in gut <italic>Porphyromonas</italic> and <italic>Prevotella corporis</italic> correlated with postmenopausal hot flashes, which may also be related to their effect on estrogen levels (<xref rid="B54" ref-type="bibr">54</xref>).</p><p>Limitations of the study include the limited number of samples and differences in age and menopausal status between the groups. On the one hand, it reflects the natural distribution observed clinically, as patients with endometrial cancer tend to be older than those with hyperplasia (<xref rid="B55" ref-type="bibr">55</xref>, <xref rid="B56" ref-type="bibr">56</xref>). In particular, Walsh et al. (<xref rid="B32" ref-type="bibr">32</xref>) also reported that postmenopausal status and age were significant modifiers of the microbiome composition. At the same time, we believe that, since the results of our research are consistent with previous studies, especially regarding <italic>Porphyromonas</italic> and <italic>Prevotella</italic>, menopause should be considered as only one of several factors that influence the outcome. The hypoestrogenism typically observed in postmenopause might potentially modulate the microbiota through interactions betwen estrogen and intraepithelial glycogen. The latter serve as a substrate for <italic>Lactobacilli</italic>, which act as antagonists to other bacteria through producing hydrogen peroxide and antimicrobial compounds. This interaction becomes even more complex when considering that multiple bacterial species can affect estrogen reabsorption and enterohepatic circulation by their &#x003b2;-glucuronidase and &#x003b2;-glucosidase enzymes that deconjugate estrogens (<xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B58" ref-type="bibr">58</xref>). Therefore, it can be hypothesized that increased activity of the deconjugating bacteria could lead to increased estrogen levels, a known risk factor for EC.</p><p>In conclusion, both vaginal and endometrial microbiota are different in terms of composition between patients with EH and EC. Several taxa were enriched in vaginal samples in patients with EC: <italic>Prevotella corporis, Porphyromonas, Streptococcus, Moryella, Criibacterium, Peptococcus niger and Clostridiales bacterium S5-A14a</italic>. We believe that these differentiating taxa found may be a hallmark of EC-associated vaginal dysbiosis. Our results therefore support previous findings suggesting differences in the composition of the genital tract microbiome, which could potentially be used for the diagnosis of EC, including the differential diagnosis of EH.</p></sec></body><back><sec sec-type="data-availability" id="s5"><title>Data availability statement</title><p>The 16S rRNA data were deposited at the NCBI sequence read archive under the BioProject PRJNA1255609.</p></sec><sec sec-type="ethics-statement" id="s6"><title>Ethics statement</title><p>The studies involving humans were approved by Almazov Centre Instituional Ethical Board. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p></sec><sec sec-type="author-contributions" id="s7"><title>Author contributions</title><p>IG: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing. EK: Funding acquisition, Writing &#x02013; review &#x00026; editing. EU: Resources, Writing &#x02013; review &#x00026; editing. ED: Investigation, Writing &#x02013; review &#x00026; editing. TP: Funding acquisition, Resources, Writing &#x02013; review &#x00026; editing. OV: Investigation, Writing &#x02013; review &#x00026; editing. AD: Investigation, Writing &#x02013; review &#x00026; editing. OK: Investigation, Writing &#x02013; review &#x00026; editing. EZ: Investigation, Writing &#x02013; review &#x00026; editing. ZR: Methodology, Writing &#x02013; review &#x00026; editing. MM: Investigation, Project administration, Resources, Writing &#x02013; review &#x00026; editing. SS: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing &#x02013; original draft.</p></sec><sec sec-type="COI-statement" id="conf1"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="ai-statement" id="s9"><title>Generative AI statement</title><p>The author(s) declare that no Gen AI was used in the creation of this manuscript.</p></sec><sec sec-type="disclaimer" id="s10"><title>Publisher's note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cronin</surname><given-names>KA</given-names></name><name><surname>Scott</surname><given-names>S</given-names></name><name><surname>Firth</surname><given-names>AU</given-names></name><name><surname>Sung</surname><given-names>H</given-names></name><name><surname>Henley</surname><given-names>SJ</given-names></name><name><surname>Sherman</surname><given-names>RL</given-names></name><etal/></person-group>. <article-title>Annual report to the nation on the status of cancer, part 1: National cancer statistics</article-title>. <source>Cancer</source>. (<year>2022</year>) <volume>128</volume>:<fpage>4251</fpage>&#x02013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1002/cncr.34479</pub-id><pub-id pub-id-type="pmid">36301149</pub-id>
</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bokhman</surname><given-names>JV</given-names></name></person-group>. <article-title>Two pathogenetic types of endometrial carcinoma</article-title>. <source>Gynecol Oncol</source>. (<year>1983</year>) <volume>15</volume>:<fpage>10</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/0090-8258(83)90111-7</pub-id><pub-id pub-id-type="pmid">6822361</pub-id>
</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kandoth</surname><given-names>C</given-names></name><name><surname>Schultz</surname><given-names>N</given-names></name><name><surname>Cherniack</surname><given-names>A</given-names></name><name><surname>Akbani</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Cancer genome atlas research N. integrated genomic characterization of endometrial carcinoma</article-title>. <source>Nature</source>. (<year>2013</year>) <volume>497</volume>:<fpage>67</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1038/nature12113</pub-id><pub-id pub-id-type="pmid">23636398</pub-id>
</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x00141;aniewski</surname><given-names>P</given-names></name><name><surname>Ilhan</surname><given-names>ZE</given-names></name><name><surname>Herbst-Kralovetz</surname><given-names>MM</given-names></name></person-group>. <article-title>The microbiome and gynaecological cancer development, prevention and therapy</article-title>. <source>Nat Rev Urol</source>. (<year>2020</year>) <volume>17</volume>:<fpage>232</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1038/s41585-020-0286-z</pub-id><pub-id pub-id-type="pmid">32071434</pub-id>
</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Su</surname><given-names>H</given-names></name><name><surname>Shi</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name></person-group>. <article-title>Endometrial microbiota from endometrial cancer and paired pericancer tissues in postmenopausal women: differences and clinical relevance</article-title>. <source>Menopause</source>. (<year>2022</year>) <volume>29</volume>:<fpage>1168</fpage>. <pub-id pub-id-type="doi">10.1097/GME.0000000000002053</pub-id><pub-id pub-id-type="pmid">36150116</pub-id>
</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000f8;ller</surname><given-names>BR</given-names></name><name><surname>Kristiansen</surname><given-names>FV</given-names></name><name><surname>Thorsen</surname><given-names>P</given-names></name><name><surname>Frost</surname><given-names>L</given-names></name><name><surname>Mogensen</surname><given-names>SC</given-names></name></person-group>. <article-title>Sterility of the uterine cavity</article-title>. <source>Acta obstetricia et gynecologica Scandinavica</source>. (<year>1995</year>) <volume>74</volume>:<fpage>216</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.3109/00016349509008942</pub-id><pub-id pub-id-type="pmid">7900526</pub-id>
</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ansbacher</surname><given-names>R</given-names></name><name><surname>Boyson</surname><given-names>WA</given-names></name><name><surname>Morris</surname><given-names>JA</given-names></name></person-group>. <article-title>Sterility of the uterine cavity</article-title>. <source>Am J Obstet Gynecol</source>. (<year>1967</year>) <volume>99</volume>:<fpage>394</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/S0002-9378(16)34549-5</pub-id><pub-id pub-id-type="pmid">4962972</pub-id>
</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Song</surname><given-names>X</given-names></name><name><surname>Wei</surname><given-names>W</given-names></name><name><surname>Zhong</surname><given-names>H</given-names></name><name><surname>Dai</surname><given-names>J</given-names></name><name><surname>Lan</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>The microbiota continuum along the female reproductive tract and its relation to uterine-related diseases</article-title>. <source>Nat Commun</source>. (<year>2017</year>) <volume>8</volume>:<fpage>875</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-017-00901-0</pub-id><pub-id pub-id-type="pmid">29042534</pub-id>
</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-Velasco</surname><given-names>JA</given-names></name><name><surname>Budding</surname><given-names>D</given-names></name><name><surname>Campe</surname><given-names>H</given-names></name><name><surname>Malfertheiner</surname><given-names>SF</given-names></name><name><surname>Hamamah</surname><given-names>S</given-names></name><name><surname>Santjohanser</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>The reproductive microbiome-clinical practice recommendations for fertility specialists</article-title>. <source>Reprod Biomed Online</source>. (<year>2020</year>) <volume>41</volume>:<fpage>443</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.rbmo.2020.06.014</pub-id><pub-id pub-id-type="pmid">32753361</pub-id>
</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Punz&#x000f3;n-Jim&#x000e9;nez</surname><given-names>P</given-names></name><name><surname>Labarta</surname><given-names>E</given-names></name></person-group>. <article-title>The impact of the female genital tract microbiome in women health and reproduction: a review</article-title>. <source>J Assist Reprod Genet</source>. (<year>2021</year>) <volume>38</volume>:<fpage>2519</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1007/s10815-021-02247-5</pub-id><pub-id pub-id-type="pmid">34110573</pub-id>
</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chalif</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Spakowicz</surname><given-names>D</given-names></name><name><surname>Quick</surname><given-names>A</given-names></name><name><surname>Arthur</surname><given-names>EK</given-names></name><name><surname>O'Malley</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>The microbiome and gynecologic cancer: cellular mechanisms and clinical applications</article-title>. <source>Int J Gynecol Cancer</source>. (<year>2023</year>) <volume>34</volume>:<fpage>317</fpage>&#x02013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1136/ijgc-2023-004894</pub-id><pub-id pub-id-type="pmid">38088183</pub-id>
</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verstraelen</surname><given-names>H</given-names></name><name><surname>Vilchez-Vargas</surname><given-names>R</given-names></name><name><surname>Desimpel</surname><given-names>F</given-names></name><name><surname>Jauregui</surname><given-names>R</given-names></name><name><surname>Vankeirsbilck</surname><given-names>N</given-names></name><name><surname>Weyers</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Characterisation of the human uterine microbiome in non-pregnant women through deep sequencing of the V1-2 region of the 16S rRNA gene</article-title>. <source>PeerJ</source>. (<year>2016</year>) <volume>4</volume>:<fpage>e1602</fpage>. <pub-id pub-id-type="doi">10.7717/peerj.1602</pub-id><pub-id pub-id-type="pmid">26823997</pub-id>
</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Andrews</surname><given-names>S</given-names></name></person-group>. <source>FastQC: A Quality Control Tool for High Throughput Sequence Data</source>. <publisher-loc>Cambridge</publisher-loc>: <publisher-name>Babraham Bioinformatics, Babraham Institute.</publisher-name> (<year>2010</year>).</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ewels</surname><given-names>P</given-names></name><name><surname>Magnusson</surname><given-names>M</given-names></name><name><surname>Lundin</surname><given-names>S</given-names></name><name><surname>K&#x000e4;ller</surname><given-names>M</given-names></name></person-group>. <article-title>MultiQC: summarize analysis results for multiple tools and samples in a single report</article-title>. <source>Bioinformatics</source>. (<year>2016</year>) <volume>32</volume>:<fpage>3047</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btw354</pub-id><pub-id pub-id-type="pmid">27312411</pub-id>
</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolger</surname><given-names>AM</given-names></name><name><surname>Lohse</surname><given-names>M</given-names></name><name><surname>Usadel</surname><given-names>B</given-names></name></person-group>. <article-title>Trimmomatic: a flexible trimmer for Illumina sequence data</article-title>. <source>Bioinformatics</source>. (<year>2014</year>) <volume>30</volume>:<fpage>2114</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btu170</pub-id><pub-id pub-id-type="pmid">24695404</pub-id>
</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callahan</surname><given-names>BJ</given-names></name><name><surname>McMurdie</surname><given-names>PJ</given-names></name><name><surname>Rosen</surname><given-names>MJ</given-names></name><name><surname>Han</surname><given-names>AW</given-names></name><name><surname>Johnson</surname><given-names>AJA</given-names></name><name><surname>Holmes</surname><given-names>SP</given-names></name></person-group>. <article-title>DADA2: High-resolution sample inference from Illumina amplicon data</article-title>. <source>Nat Methods</source>. (<year>2016</year>) <volume>13</volume>:<fpage>581</fpage>&#x02013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.3869</pub-id><pub-id pub-id-type="pmid">27214047</pub-id>
</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirdita</surname><given-names>M</given-names></name><name><surname>Steinegger</surname><given-names>M</given-names></name><name><surname>Breitwieser</surname><given-names>F</given-names></name><name><surname>S&#x000f6;ding</surname><given-names>J</given-names></name><name><surname>Levy Karin</surname><given-names>E</given-names></name></person-group>. <article-title>Fast and sensitive taxonomic assignment to metagenomic contigs</article-title>. <source>Bioinformatics</source>. (<year>2021</year>) <volume>37</volume>:<fpage>3029</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btab184</pub-id><pub-id pub-id-type="pmid">33734313</pub-id>
</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMurdie</surname><given-names>PJ</given-names></name><name><surname>Holmes</surname><given-names>S</given-names></name></person-group>. <article-title>phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data</article-title>. <source>PLoS ONE</source>. (<year>2013</year>) <volume>8</volume>:<fpage>e61217</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0061217</pub-id><pub-id pub-id-type="pmid">23630581</pub-id>
</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Dong</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Niu</surname><given-names>C</given-names></name></person-group>. <article-title>microbiomeMarker: an R/Bioconductor package for microbiome marker identification and visualization</article-title>. <source>Bioinformatics</source>. (<year>2022</year>) <volume>38</volume>:<fpage>4027</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btac438</pub-id><pub-id pub-id-type="pmid">35771644</pub-id>
</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Oksanen</surname><given-names>J</given-names></name></person-group>. <source>Vegan: Community Ecology Package</source>. (<year>2010</year>). Available online at: <ext-link xlink:href="https://vegan.r-forge.r-project.org/" ext-link-type="uri">https://vegan.r-forge.r-project.org/</ext-link> (accessed September 1, 2024).</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>JM</given-names></name><name><surname>Chase</surname><given-names>DM</given-names></name><name><surname>Herbst-Kralovetz</surname><given-names>MM</given-names></name></person-group>. <article-title>Uterine microbiota: residents, tourists, or invaders?</article-title>
<source>Front Immunol</source>. (<year>2018</year>) <volume>9</volume>:<fpage>208</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.00208</pub-id><pub-id pub-id-type="pmid">29552006</pub-id>
</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Grau</surname><given-names>I</given-names></name><name><surname>Simon</surname><given-names>C</given-names></name><name><surname>Moreno</surname><given-names>I</given-names></name></person-group>. <article-title>Uterine microbiome&#x02014;low biomass and high expectations</article-title>. <source>Biol Reprod</source>. (<year>2019</year>) <volume>101</volume>:<fpage>1102</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1093/biolre/ioy257</pub-id><pub-id pub-id-type="pmid">30544156</pub-id>
</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agostinis</surname><given-names>C</given-names></name><name><surname>Mangogna</surname><given-names>A</given-names></name><name><surname>Bossi</surname><given-names>F</given-names></name><name><surname>Ricci</surname><given-names>G</given-names></name><name><surname>Kishore</surname><given-names>U</given-names></name><name><surname>Bulla</surname><given-names>R</given-names></name></person-group>. <article-title>Uterine immunity and microbiota: a shifting paradigm</article-title>. <source>Front Immunol</source>. (<year>2019</year>) <volume>10</volume>:<fpage>2387</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.02387</pub-id><pub-id pub-id-type="pmid">31681281</pub-id>
</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gressel</surname><given-names>GM</given-names></name><name><surname>Usyk</surname><given-names>M</given-names></name><name><surname>Frimer</surname><given-names>M</given-names></name><name><surname>Kuo</surname><given-names>D</given-names></name><name><surname>Burk</surname><given-names>RD</given-names></name></person-group>. <article-title>Characterization of the endometrial, cervicovaginal and anorectal microbiota in post-menopausal women with endometrioid and serous endometrial cancers</article-title>. <source>PLoS ONE</source>. (<year>2021</year>) <volume>16</volume>:<fpage>e0259188</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0259188</pub-id><pub-id pub-id-type="pmid">34739493</pub-id>
</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelzer</surname><given-names>ES</given-names></name><name><surname>Willner</surname><given-names>D</given-names></name><name><surname>Buttini</surname><given-names>M</given-names></name><name><surname>Huygens</surname><given-names>F</given-names></name></person-group>. <article-title>A role for the endometrial microbiome in dysfunctional menstrual bleeding</article-title>. <source>Antonie Van Leeuwenhoek</source>. (<year>2018</year>) <volume>111</volume>:<fpage>933</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1007/s10482-017-0992-6</pub-id><pub-id pub-id-type="pmid">29299770</pub-id>
</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Tang</surname><given-names>H</given-names></name><name><surname>Zeng</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>R</given-names></name></person-group>. <article-title>Microbiota composition and distribution along the female reproductive tract of women with endometriosis</article-title>. <source>Ann Clin Microbiol Antimicrob</source>. (<year>2020</year>) <volume>19</volume>:<fpage>1</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1186/s12941-020-00356-0</pub-id><pub-id pub-id-type="pmid">31918737</pub-id>
</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Wei</surname><given-names>K</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Wei</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Identification of uterine microbiota in infertile women receiving in vitro fertilization with and without chronic endometritis</article-title>. <source>Front Cell Dev Biol</source>. (<year>2021</year>) <volume>9</volume>:<fpage>693267</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2021.693267</pub-id><pub-id pub-id-type="pmid">34485281</pub-id>
</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Han</surname><given-names>W</given-names></name><name><surname>Ban</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>T</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name></person-group>. <article-title>Vaginal and tumor microbiomes in gynecological cancer</article-title>. <source>Oncol Lett</source>. (<year>2023</year>) <volume>25</volume>:<fpage>1</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.3892/ol.2023.13739</pub-id><pub-id pub-id-type="pmid">36419753</pub-id>
</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blaser</surname><given-names>MJ</given-names></name><name><surname>Kirschner</surname><given-names>D</given-names></name></person-group>. <article-title>The equilibria that allow bacterial persistence in human hosts</article-title>. <source>Nature</source>. (<year>2007</year>) <volume>449</volume>:<fpage>843</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/nature06198</pub-id><pub-id pub-id-type="pmid">17943121</pub-id>
</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caselli</surname><given-names>E</given-names></name><name><surname>Soffritti</surname><given-names>I</given-names></name><name><surname>D'Accolti</surname><given-names>M</given-names></name><name><surname>Piva</surname><given-names>I</given-names></name><name><surname>Greco</surname><given-names>P</given-names></name><name><surname>Bonaccorsi</surname><given-names>G</given-names></name></person-group>. <article-title>Atopobium vaginae and <italic>Porphyromonas somerae</italic> induce proinflammatory cytokines expression in endometrial cells: a possible implication for endometrial cancer?</article-title>
<source>Cancer Managem Res</source>. (<year>2019</year>) <volume>11</volume>:<fpage>8571</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.2147/CMAR.S217362</pub-id><pub-id pub-id-type="pmid">31576164</pub-id>
</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walther-Ant&#x000f3;nio</surname><given-names>MR</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Multinu</surname><given-names>F</given-names></name><name><surname>Hokenstad</surname><given-names>A</given-names></name><name><surname>Distad</surname><given-names>TJ</given-names></name><name><surname>Cheek</surname><given-names>EH</given-names></name><etal/></person-group>. <article-title>Potential contribution of the uterine microbiome in the development of endometrial cancer</article-title>. <source>Genome Med</source>. (<year>2016</year>) <volume>8</volume>:<fpage>1</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1186/s13073-016-0368-y</pub-id><pub-id pub-id-type="pmid">26750923</pub-id>
</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walsh</surname><given-names>DM</given-names></name><name><surname>Hokenstad</surname><given-names>AN</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Sung</surname><given-names>J</given-names></name><name><surname>Jenkins</surname><given-names>GD</given-names></name><name><surname>Chia</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Postmenopause as a key factor in the composition of the Endometrial Cancer Microbiome (ECbiome)</article-title>. <source>Sci Rep</source>. (<year>2019</year>) <volume>9</volume>:<fpage>19213</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-019-55720-8</pub-id><pub-id pub-id-type="pmid">31844128</pub-id>
</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hakimjavadi</surname><given-names>H</given-names></name><name><surname>George</surname><given-names>SH</given-names></name><name><surname>Taub</surname><given-names>M</given-names></name><name><surname>Dodds</surname><given-names>LV</given-names></name><name><surname>Sanchez-Covarrubias</surname><given-names>AP</given-names></name><name><surname>Huang</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>The vaginal microbiome is associated with endometrial cancer grade and histology</article-title>. <source>Cancer Res Commun</source>. (<year>2022</year>) <volume>2</volume>:<fpage>447</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1158/2767-9764.CRC-22-0075</pub-id><pub-id pub-id-type="pmid">35928983</pub-id>
</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Gu</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>Q</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Wan</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Integrated analysis of microbiome and transcriptome data reveals the interplay between commensal bacteria and fibrin degradation in endometrial cancer</article-title>. <source>Front Cell Infect Microbiol</source>. (<year>2021</year>) <volume>11</volume>:<fpage>748558</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2021.748558</pub-id><pub-id pub-id-type="pmid">34621695</pub-id>
</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sayehmiri</surname><given-names>F</given-names></name><name><surname>Sayehmiri</surname><given-names>K</given-names></name><name><surname>Asadollahi</surname><given-names>K</given-names></name><name><surname>Soroush</surname><given-names>S</given-names></name><name><surname>Bogdanovic</surname><given-names>L</given-names></name><name><surname>Jalilian</surname><given-names>FA</given-names></name><etal/></person-group>. <article-title>The prevalence rate of <italic>Porphyromonas gingivalis</italic> and its association with cancer: A systematic review and meta-analysis</article-title>. <source>Int J Immunopathol Pharmacol</source>. (<year>2015</year>) <volume>28</volume>:<fpage>160</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1177/0394632015586144</pub-id><pub-id pub-id-type="pmid">26002887</pub-id>
</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Yin</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Relationship between vaginal and oral microbiome in patients of human papillomavirus (HPV) infection and cervical cancer</article-title>. <source>J Transl Med</source>. (<year>2024</year>) <volume>22</volume>:<fpage>396</fpage>. <pub-id pub-id-type="doi">10.1186/s12967-024-05124-8</pub-id><pub-id pub-id-type="pmid">38685022</pub-id>
</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>K&#x000f6;n&#x000f6;nen</surname><given-names>E</given-names></name><name><surname>Gursoy</surname><given-names>UK</given-names></name></person-group>. <article-title>Oral Prevotella species and their connection to events of clinical relevance in gastrointestinal and respiratory tracts</article-title>. <source>Front Microbiol</source>. (<year>2022</year>) <volume>12</volume>:<fpage>798763</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2021.798763</pub-id><pub-id pub-id-type="pmid">35069501</pub-id>
</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciodaro</surname><given-names>F</given-names></name><name><surname>Gazia</surname><given-names>F</given-names></name><name><surname>Galletti</surname><given-names>B</given-names></name><name><surname>Galletti</surname><given-names>F</given-names></name></person-group>. <article-title>Hyperbaric oxygen therapy in a case of cervical abscess extending to anterior mediastinum, with isolation of <italic>Prevotella corporis</italic></article-title>. <source>BMJ Case Reports CP.</source> (<year>2019</year>) <volume>12</volume>:<fpage>e229873</fpage>. <pub-id pub-id-type="doi">10.1136/bcr-2019-229873</pub-id><pub-id pub-id-type="pmid">31296620</pub-id>
</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hillier</surname><given-names>SL</given-names></name></person-group>. <article-title>Diagnostic microbiology of bacterial vaginosis</article-title>. <source>Am J Obstet Gynecol</source>. (<year>1993</year>) <volume>169</volume>:<fpage>455</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/0002-9378(93)90340-O</pub-id><pub-id pub-id-type="pmid">8357044</pub-id>
</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mikamo</surname><given-names>H</given-names></name><name><surname>Izumi</surname><given-names>K</given-names></name><name><surname>Ito</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>Ueno</surname><given-names>K</given-names></name><name><surname>Tamaya</surname><given-names>T</given-names></name></person-group>. <article-title>Internal bacterial flora of solid uterine cervical cancer</article-title>. <source>Kansenshogaku Zasshi</source>. (<year>1993</year>) <volume>67</volume>:<fpage>11</fpage>. <pub-id pub-id-type="doi">10.11150/kansenshogakuzasshi1970.67.1057</pub-id><pub-id pub-id-type="pmid">8270797</pub-id>
</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Han</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>T</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name></person-group>. <article-title>Highly specific vaginal microbiome signature for gynecological cancers</article-title>. <source>Open Life Sci</source>. (<year>2024</year>) <volume>19</volume>:<fpage>20220850</fpage>. <pub-id pub-id-type="doi">10.1515/biol-2022-0850</pub-id><pub-id pub-id-type="pmid">38633411</pub-id>
</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ilhan</surname><given-names>ZE</given-names></name><name><surname>&#x00141;aniewski</surname><given-names>P</given-names></name><name><surname>Tonachio</surname><given-names>A</given-names></name><name><surname>Herbst-Kralovetz</surname><given-names>MM</given-names></name></person-group>. <article-title>Members of Prevotella genus distinctively modulate innate immune and barrier functions in a human three-dimensional endometrial epithelial cell model</article-title>. <source>J Infect Dis</source>. (<year>2020</year>) <volume>222</volume>:<fpage>2082</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jiaa324</pub-id><pub-id pub-id-type="pmid">32515473</pub-id>
</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roachford</surname><given-names>OSE</given-names></name><name><surname>Alleyne</surname><given-names>AT</given-names></name><name><surname>Nelson</surname><given-names>KE</given-names></name></person-group>. <article-title>Insights into the vaginal microbiome in a diverse group of women of African, Asian and European ancestries</article-title>. <source>PeerJ</source>. (<year>2022</year>) <volume>10</volume>:<fpage>e14449</fpage>. <pub-id pub-id-type="doi">10.7717/peerj.14449</pub-id><pub-id pub-id-type="pmid">36518275</pub-id>
</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Qin</surname><given-names>J</given-names></name><name><surname>Shen</surname><given-names>D</given-names></name><name><surname>Qiao</surname><given-names>Y</given-names></name><name><surname>Kong</surname><given-names>B</given-names></name></person-group>. <article-title>Associations between bacterial vaginosis, candida vaginitis, trichomonas vaginalis, and vaginal pathogenic community in Chinese women</article-title>. <source>Am J Transl Res</source>. (<year>2021</year>) <volume>13</volume>:<fpage>7148</fpage>. <pub-id pub-id-type="pmid">34306475</pub-id>
</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsementzi</surname><given-names>D</given-names></name><name><surname>Pena-Gonzalez</surname><given-names>A</given-names></name><name><surname>Bai</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>YJ</given-names></name><name><surname>Patel</surname><given-names>P</given-names></name><name><surname>Shelton</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Comparison of vaginal microbiota in gynecologic cancer patients pre-and post-radiation therapy and healthy women</article-title>. <source>Cancer Med</source>. (<year>2020</year>) <volume>9</volume>:<fpage>3714</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1002/cam4.3027</pub-id><pub-id pub-id-type="pmid">32237205</pub-id>
</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Xin</surname><given-names>Y</given-names></name></person-group>. <article-title>The role of the gut microbiota in gastric cancer: The immunoregulation and immunotherapy</article-title>. <source>Front Immunol</source>. (<year>2023</year>) <volume>14</volume>:<fpage>1183331</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2023.1183331</pub-id><pub-id pub-id-type="pmid">37457738</pub-id>
</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>BB</given-names></name></person-group>. <article-title>Vaginitis: beyond the basics</article-title>. <source>Obstet Gynecol Clini</source>. (<year>2017</year>) <volume>44</volume>:<fpage>159</fpage>&#x02013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1016/j.ogc.2017.02.010</pub-id><pub-id pub-id-type="pmid">28499528</pub-id>
</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pignatelli</surname><given-names>P</given-names></name><name><surname>Curia</surname><given-names>MC</given-names></name><name><surname>Tenore</surname><given-names>G</given-names></name><name><surname>Bondi</surname><given-names>D</given-names></name><name><surname>Piattelli</surname><given-names>A</given-names></name><name><surname>Romeo</surname><given-names>U</given-names></name></person-group>. <article-title>Oral bacteriome and oral potentially malignant disorders: a systematic review of the associations</article-title>. <source>Arch Oral Biol</source>. (<year>2024</year>). 160:105891. <pub-id pub-id-type="doi">10.1016/j.archoralbio.2024.105891</pub-id><pub-id pub-id-type="pmid">38295615</pub-id>
</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griesenauer</surname><given-names>B</given-names></name><name><surname>Xing</surname><given-names>Y</given-names></name><name><surname>Fortney</surname><given-names>KR</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Gonz&#x000e1;lez-Beiras</surname><given-names>C</given-names></name><name><surname>Nelson</surname><given-names>DE</given-names></name><etal/></person-group>. <article-title>Two Streptococcus pyogenes emm types and several anaerobic bacterial species are associated with idiopathic cutaneous ulcers in children after community-based mass treatment with azithromycin</article-title>. <source>PLOS Negl Trop Dis</source>. (<year>2022</year>) <volume>16</volume>:<fpage>e0011009</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0011009</pub-id><pub-id pub-id-type="pmid">36534698</pub-id>
</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neiterman</surname><given-names>RH</given-names></name><name><surname>Salman</surname><given-names>L</given-names></name><name><surname>Meisel-Sharon</surname><given-names>S</given-names></name><name><surname>Noy</surname><given-names>TB</given-names></name><name><surname>Carmel</surname><given-names>RR</given-names></name><name><surname>Hantisteanu</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>PR052/# 439 Distinct vaginal microbiome ovarian cancer patients-a possible screening and prognostic biomarker?</article-title>
<source>BMJ Special J</source>. (<year>2023</year>) <volume>33</volume>:<fpage>A60</fpage>&#x02013;<lpage>1</lpage>. <pub-id pub-id-type="doi">10.1136/ijgc-2023-IGCS.93</pub-id></mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeber-Lubecka</surname><given-names>N</given-names></name><name><surname>Kulecka</surname><given-names>M</given-names></name><name><surname>Lindner</surname><given-names>B</given-names></name><name><surname>Krynicki</surname><given-names>R</given-names></name><name><surname>Paziewska</surname><given-names>A</given-names></name><name><surname>Nowakowski</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Increased diversity of a cervical microbiome associates with cervical cancer</article-title>. <source>Front Oncol</source>. (<year>2022</year>) <volume>12</volume>:<fpage>1005537</fpage>. <pub-id pub-id-type="doi">10.3389/fonc.2022.1005537</pub-id><pub-id pub-id-type="pmid">36249017</pub-id>
</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwa</surname><given-names>M</given-names></name><name><surname>Plottel</surname><given-names>CS</given-names></name><name><surname>Blaser</surname><given-names>MJ</given-names></name><name><surname>Adams</surname><given-names>S</given-names></name></person-group>. <article-title>The intestinal microbiome and estrogen receptor-positive female breast cancer</article-title>. <source>J Nat Cancer Institute</source>. (<year>2016</year>) <volume>108</volume>:<fpage>djw029</fpage>. <pub-id pub-id-type="doi">10.1093/jnci/djw029</pub-id><pub-id pub-id-type="pmid">27107051</pub-id>
</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cotton</surname><given-names>S</given-names></name><name><surname>Clayton</surname><given-names>CA</given-names></name><name><surname>Tropini</surname><given-names>C</given-names></name></person-group>. <article-title>Microbial endocrinology: the mechanisms by which the microbiota influences host sex steroids</article-title>. <source>Trends Microbiol</source>. (<year>2023</year>) <volume>31</volume>:<fpage>1131</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.tim.2023.03.010</pub-id><pub-id pub-id-type="pmid">37100633</pub-id>
</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahleova</surname><given-names>H</given-names></name><name><surname>Holtz</surname><given-names>DN</given-names></name><name><surname>Strom</surname><given-names>N</given-names></name><name><surname>La Reau</surname><given-names>A</given-names></name><name><surname>Kolipaka</surname><given-names>S</given-names></name><name><surname>Schmidt</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>A dietary intervention for postmenopausal hot flashes: a potential role of gut microbiome. An exploratory analysis</article-title>. <source>Complement Therap Med</source>. (<year>2023</year>) <volume>79</volume>:<fpage>103002</fpage>. <pub-id pub-id-type="doi">10.1016/j.ctim.2023.103002</pub-id><pub-id pub-id-type="pmid">37949415</pub-id>
</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reed</surname><given-names>SD</given-names></name><name><surname>Newton</surname><given-names>KM</given-names></name><name><surname>Clinton</surname><given-names>WL</given-names></name><name><surname>Epplein</surname><given-names>M</given-names></name><name><surname>Garcia</surname><given-names>R</given-names></name><name><surname>Allison</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Incidence of endometrial hyperplasia</article-title>. <source>Am J Obstet Gynecol</source>. (<year>2009</year>) <volume>200</volume>:<fpage>678</fpage>&#x02013;<lpage>e1</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajog.2009.02.032</pub-id><pub-id pub-id-type="pmid">19393600</pub-id>
</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lurie</surname><given-names>G</given-names></name><name><surname>Gaudet</surname><given-names>M</given-names></name><name><surname>Spurdle</surname><given-names>A</given-names></name><name><surname>Carney</surname><given-names>M</given-names></name><name><surname>Wilkens</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Epidemiology of Endometrial Cancer Consortium (E2C2): the obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white women</article-title>. <source>PLoS ONE</source>. (<year>2011</year>) <volume>6</volume>:<fpage>e16756</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0016756</pub-id><pub-id pub-id-type="pmid">21347432</pub-id>
</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McIntosh</surname><given-names>FM</given-names></name><name><surname>Maison</surname><given-names>N</given-names></name><name><surname>Holtrop</surname><given-names>G</given-names></name><name><surname>Young</surname><given-names>P</given-names></name><name><surname>Stevens</surname><given-names>VJ</given-names></name><name><surname>Ince</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Phylogenetic distribution of genes encoding &#x003b2;-glucuronidase activity in human colonic bacteria and the impact of diet on faecal glycosidase activities</article-title>. <source>Environ Microbiol</source>. (<year>2012</year>) <volume>14</volume>:<fpage>1876</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1111/j.1462-2920.2012.02711.x</pub-id><pub-id pub-id-type="pmid">22364273</pub-id>
</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plottel</surname><given-names>CS</given-names></name><name><surname>Blaser</surname><given-names>MJ</given-names></name></person-group>. <article-title>Microbiome and malignancy</article-title>. <source>Cell Host Microbe</source>. (<year>2011</year>) <volume>10</volume>:<fpage>324</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2011.10.003</pub-id><pub-id pub-id-type="pmid">22018233</pub-id>
</mixed-citation></ref></ref-list></back></article>